Show simple item record

dc.contributor.authorBreathett, Khadijah
dc.contributor.authorMaffett, Scott
dc.contributor.authorForaker, Randi E.
dc.contributor.authorSturdivant, Rod
dc.contributor.authorMoon, Kristina
dc.contributor.authorHasan, Ayesha
dc.contributor.authorFranco, Veronica
dc.contributor.authorSmith, Sakima
dc.contributor.authorLampert, Brent C.
dc.contributor.authorEmani, Sitaramesh
dc.contributor.authorHaas, Garrie
dc.contributor.authorKahwash, Rami
dc.contributor.authorHershberger, Ray E.
dc.contributor.authorBinkley, Philip F.
dc.contributor.authorHelmkamp, Laura
dc.contributor.authorColborn, Kathryn
dc.contributor.authorPeterson, Pamela N.
dc.contributor.authorSweitzer, Nancy
dc.contributor.authorAbraham, William T.
dc.date.accessioned2018-10-10T22:20:28Z
dc.date.available2018-10-10T22:20:28Z
dc.date.issued2018-08
dc.identifier.citationBreathett, K., Maffett, S., Foraker, R. E., Sturdivant, R., Moon, K., Hasan, A., ... & Haas, G. (2018). Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education. The American journal of medicine, 131(8), 974-978. https://doi.org/10.1016/j.amjmed.2018.02.017en_US
dc.identifier.issn00029343
dc.identifier.pmid29555457
dc.identifier.doi10.1016/j.amjmed.2018.02.017
dc.identifier.urihttp://hdl.handle.net/10150/630110
dc.description.abstractBACKGROUND: Heart failure education programs are not standardized. The best form of education is unclear. We evaluated whether addition of a novel tablet application to nurse practitioner (NP) education was superior to NP education alone in reducing 30-day readmission after heart failure hospitalization. METHODS: From February 2015-March 2016. patients admitted to a quaternary academic center with primary diagnosis of heart failure were randomized to 1) treatment - NP education plus tablet application (interactive conditional logic program that flags patient questions to medical staff), or 2) control - NP education. The primary outcome was reduction in 30-day readmission rate. Secondary outcomes included satisfaction and education assessed via survey. RESULTS: Randomization included 60 patients to treatment and 66 to control. A total of 13 patients withdrew prior to intervention (treatment n = 4, control n = 1) or were lost to follow-up (treatment n = 3, control n = 5). The 30-day readmission rate trended lower for treatment compared with control, but results were not statistically significant (13.2% [7/53]. 26.7% [16/60]. respectively, P = .08). Similarly, satisfaction trended higher with treatment than control (P = .08). Treatment patients rated explanations from their physicians higher than control (Always: 83.7%. 55.8%, respectively, P = .01). CONCLUSIONS: NP education plus tablet use was not associated with significantly lower 30-day readmission rates in comparison with NP alone, but a positive trend was seen. Patient satisfaction trended higher and heart failure explanations were better with NP education plus tablet. A larger study is needed to determine if NP education plus tablet reduces readmission rates following heart failure admission. (C) 2018 Elsevier Inc. All rights reserved.en_US
dc.description.sponsorshipOhio State University Department of Medicine seed grant award; National Institutes of Health (NIH) [L60 MD010857]; University of Colorado, Department of Medicine, Health Services Research Development Grant Award; University of Arizona Health Sciences, Strategic Priorities Faculty Initiative Granten_US
dc.language.isoenen_US
dc.publisherELSEVIER SCIENCE INCen_US
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0002934318302043en_US
dc.rights© 2018 Elsevier Inc. All rights reserved.en_US
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectEducational technologyen_US
dc.subjectHeart failureen_US
dc.subjectNurse practitioneren_US
dc.subjectPatient educationen_US
dc.subjectReadmissionen_US
dc.titlePilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Educationen_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizona, Sarver Heart Ctr, Div Cardiovasc Meden_US
dc.identifier.journalAMERICAN JOURNAL OF MEDICINEen_US
dc.description.note12 month embargo; published online: 16 March 2018en_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal accepted manuscripten_US
dc.source.journaltitleThe American Journal of Medicine
dc.source.volume131
dc.source.issue8
dc.source.beginpage974
dc.source.endpage978


Files in this item

Thumbnail
Name:
Manuscript_Brief_Observation_C ...
Size:
294.5Kb
Format:
PDF
Description:
Final Accepted Manuscript

This item appears in the following Collection(s)

Show simple item record